Virtual reality and simulator training to reduce distracted driving in teens with ADHD
Official title: Improving ADHD Teen Driving - Virtual Reality
Run by Children's Hospital Medical Center, Cincinnati · NCT06960980 · Data updated 2026-11-12
This program will test two training approaches—one using virtual reality and one using a driving simulator—to help licensed teens with ADHD keep their eyes on the road and reduce crash risk.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years to 19 Years |
| Sex | All |
| Enrollment | 204 (estimated) |
| Sponsor | Children's Hospital Medical Center, Cincinnati Academic / other |
| Locations | 1 site (Cincinnati, Ohio) |
| Status | Recruiting |
| Started | September 11, 2025 |
| Main results expected | August 31, 2029 |
| Study ends | August 31, 2029 |
| Registry record updated | February 23, 2026 |
| Trial ID | NCT06960980 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Licensed teens aged 16–19 who meet DSM criteria for ADHD, drive unsupervised at least 3 hours per week, have an IQ ≥80, and have a parent willing to take part.
✕Probably not a fit
Teens who cannot pause ADHD or psychotropic medications for assessment days, are at risk for motion sickness, have significant neurological injury, substance dependence, or require glasses to see the secondary tasks may not be eligible or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional program compares the existing FOCAL+ simulator training with a new VR-FOCAL+ version designed to be lower-cost and easier to deliver. Both approaches train teens to reduce long glances away from the roadway during secondary tasks and measure gaze behavior and driving performance in simulated assessments. Participants are licensed drivers aged 16–19 with DSM-diagnosed ADHD, an IQ ≥80, and regular unsupervised driving, with a parent willing to participate. Outcomes include reductions in extended off-road glances and driving performance measures related to lane position and crash/near-crash events.
Why it matters
Potential benefit: If successful, the training could reduce long distracted glances and lower crash risk for teen drivers with ADHD.
How similar studies have gone: Prior randomized work with the original FOCAL+ program showed about 41% fewer long glances and roughly 40% lower crash/near-crash risk over a year compared with control training.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged 16-19. 2. Teens will meet DSM ADHD criteria for ADHD-Predominantly Inattentive Presentation or ADHD-Combined Presentation based on the K-SADS interview. 3. Possess a valid driver's license and regularly spend at least 3 hours per week engaged in unsupervised driving. 4. IQ ≥80 as measured by the Kauffman Brief Intelligence Scale - Second Edition (KBIT-2). 5. Parent willing to participate. Exclusion Criteria: 1. On ADHD medication that cannot be washed out on assessment days. 2. Drug or alcohol dependence based on self-report on the Simple Screening Instrument for Alcohol and Other Drugs survey. 3. On psychotropic or neuroleptic medications. 4. At-risk for motion sickness in the driving simulator or in virtual reality. 5. History of moderate to severe head trauma, neurological disorder, or any other organic disorder that could possibly affect brain function. 6. Cannot see the secondary task stimuli without the use of glasses (contacts acceptable).
Where it's running
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States Recruiting
Study contacts
- Principal investigator: Jeff N Epstein, Ph.D. — Children's Hospital Medical Center, Cincinnati
- Study coordinator: Clinical Research Coordinator
- Email: ADHDdriving@cchmc.org
- Phone: 513-636-0007
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Micronutrient and Chronotherapy for ADHD in children ages 6-12
This 12-week trial tests whether a broad-spectrum vitamin/mineral supplement plus guidance on sleep and meal timing can help reduce ADHD symptoms in children aged 6–12.
-
Home-based brain-controlled game therapy for children with ADHD
This study will test whether home-based brain-controlled game therapy can help reduce core ADHD symptoms in children aged 7 to 11 with mild to moderate ADHD.
-
Probiotics for children with ADHD: gut-brain axis impact
This study tests whether daily probiotics help kids with ADHD by influencing the gut-brain connection, compared with a placebo.
-
Predicting ADHD in middle-school children from foot pressure and posture measurements
Researchers will try to see if foot pressure and posture measurements can help predict ADHD in middle-school-aged children.
-
Evaluating EB-1020 for treating adult ADHD
This study is testing if a new medication called EB-1020 can help adults with ADHD manage their symptoms better than a placebo.
-
Long-term treatment with EB-1020 for adults with ADHD
This study is testing if a new ADHD medication called EB-1020 is safe and effective for adults who have already tried it in a previous trial over a year-long period.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.